25.11.2016 • NewsElaine BurridgePatentSolvay

Solvay Wins More Rare Earths Disputes

(c) Pierre Desrosiers/Shutterstock
(c) Pierre Desrosiers/Shutterstock

Solvay has won another two patent cases against affiliates of Neo Performance Materials relating to its range of OPtalys cerium/zirconium mixed oxides products. The Belgian group has been involved in an ongoing dispute over the rare earths with Neo Performance Materials, which was formerly known as Molycorp. Headquartered in Toronto, Canada, Molycorp emerged from Chapter 11 bankruptcy protection on Aug. 31.

Courts in Germany and China have confirmed the validity of a key Solvay patent. On Oct. 25, the German Federal Patent Court accepted a version of the patent, which had expired in June 2016, from which only “economically irrelevant” binary products were excluded. Solvay said it will now pursue the corresponding infringement procedure in the Düsseldorf district court, which could entitle it to further damages.

Meanwhile, on Oct. 20, the Chinese Patent Reexamination Board fully rejected the move by Neo affiliate Zibo Jiahua New Materials Resources to invalidate Solvay’s patent in China. Both decisions are subject to appeal. Solvay also sued Neo in the UK earlier this year, claiming infringement of a patent held by its subsidiary Anan Kasei on ceric oxide products.

Rare earth oxides are used in automotive catalysts to abate noxious gases from engine exhausts. Increasingly strict air quality standards are requiring ever more complex formulated rare earth oxides as a result.

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

Free Virtual Event

Vaccine Manufacturing
Bioprocess Forum

Vaccine Manufacturing

Join global experts and innovators for a two-day virtual event exploring the latest breakthroughs and best practices in vaccine manufacturing. Discover how new technologies and process innovations are shaping the future of vaccine production, safety, and scalability.

most read

Photo
19.03.2025 • News

Arkema Launches Acrylic Acid Purification Project

Arkema has announced the launch of its Carat Project at its Carling site in France. This initiative aims to enhance the capabilities and sustainability of the facility, which specializes in producing acrylic monomers and superabsorbent polymers.

Photo
22.04.2025 • News

BASF Divests Two Joint Ventures in China

BASF has divested its shares in the joint venture companies, BASF Markor Chemical Manufacturing (Xinjiang) Co., Ltd. and Markor Meiou Chemical (Xinjiang) Co., Ltd. in Korla, China, to Verde Chemical Singapore Pte. Ltd.

Photo
13.03.2025 • News

Roche and Zealand Pharma Collaborate on Weight Management Drug

Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.